Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Belani

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Seminars in Oncology|April 6, 1999
Incorporation of paclitaxel and carboplatin in combined-modality therapy for locally advanced non-small cell lung cancerC P Belani
Seminars in Oncology|August 1, 1993
Multimodality management of regionally advanced non-small-cell lung cancerC P Belani
Clinical Lung Cancer|December 9, 2003
Lung cancer: search for a markerC P Belani
Clinical Lung Cancer|January 21, 2004
Non-small-cell lung cancer have we reached a "chemotherapy efficacy plateau"?C P Belani
Oncology (Williston Park, N.Y.)|August 1, 1997
Docetaxel in combination with platinums in patients with advanced non-small-cell lung cancerC P Belani
Oncology (Williston Park, N.Y.)|March 28, 1998
Paclitaxel/carboplatin in the treatment of non-small-cell lung cancerC P Belani
Clinical Lung Cancer|January 22, 2004
Lung cancer in the new millenniumC P Belani
Clinical Lung Cancer|January 15, 2004
Targets...targets...targets... Targeted therapies in lung cancerC P Belani
Chest|April 25, 2000
Paclitaxel and docetaxel combinations in non-small cell lung cancerC P Belani
Seminars in Oncology|August 15, 1998
Single agents in the second-line treatment of non-small cell lung cancerC P Belani
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Seminars in Oncology|April 6, 1999
Incorporation of paclitaxel and carboplatin in combined-modality therapy for locally advanced non-small cell lung cancerC P Belani
Seminars in Oncology|August 1, 1993
Multimodality management of regionally advanced non-small-cell lung cancerC P Belani
Clinical Lung Cancer|December 9, 2003
Lung cancer: search for a markerC P Belani
Clinical Lung Cancer|January 21, 2004
Non-small-cell lung cancer have we reached a "chemotherapy efficacy plateau"?C P Belani
Oncology (Williston Park, N.Y.)|August 1, 1997
Docetaxel in combination with platinums in patients with advanced non-small-cell lung cancerC P Belani
Oncology (Williston Park, N.Y.)|March 28, 1998
Paclitaxel/carboplatin in the treatment of non-small-cell lung cancerC P Belani
Clinical Lung Cancer|January 22, 2004
Lung cancer in the new millenniumC P Belani
Clinical Lung Cancer|January 15, 2004
Targets...targets...targets... Targeted therapies in lung cancerC P Belani
Chest|April 25, 2000
Paclitaxel and docetaxel combinations in non-small cell lung cancerC P Belani
Seminars in Oncology|August 15, 1998
Single agents in the second-line treatment of non-small cell lung cancerC P Belani
Pageof 9